transparent gif
AlzheimerSupport.com Home  
Your Alzheimer's Disease Library Information Resource - Gingko and Alzheimer's Disease
Alzheimers Home Page Alzheimers Library Alzheimers Treatment and Research Email bulletins Alzheimers Products Alzheimers Community Area Alzheimers About Us transparent gif transparent gif
transparent gif
background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
 Alzheimers Info.
Alzheimers Resources

Your Support Funds Research & Advocacy

Gingko Proves to be an Effective Alzheimer's Treatment

by Wettstein A Stadtarztlicher Dienst, Zurich
AlzheimerSupport.com

04-13-2000
SUMMARY:
Researchers investigated the efficacy of a family of drugs used to treat Alzheimer's as opposed to treatment with Ginko extract. Study results show that there is not a significant difference between receiving treatment using a drug or treatment using Ginko extract. Researchers concluded by noting that Ginkgo extract should be considered equally effective in the treatment of mild to moderate Alzheimer's dementia.

ABSTRACT:

The efficacy of four cholinesterase - an enzyme that hydrolyzes (adds water to) choline (a B vitamin) esters and is found mainly in blood plasma - inhibitors (tacrine, donepezil, rivastigmine, metrifonate) and Ginkgo special extract EGb 761 in Alzheimer's disease were compared. The differences in the effects of the active substance and placebo on cognition were measured on the ADAS-Cog scale, taking into account the different degrees of dementia in the various studies and the dropout rate due to adverse drug reactions.

Efficacy, expressed as the delay in symptom progression or the difference in response rate between active substance and placebo, showed no major differences between the four cholinesterase inhibitors and the Ginkgo special extract. Only tacrine exhibited a high dropout rate due to adverse drug reactions.

In view of this, the subject of new prescriptions should be critically reviewed. Second-generation cholinesterase inhibitors (donepezil, rivastigmine, metrifonate) and Ginkgo special extract EGb 761 should be considered equally effective in the treatment of mild to moderate Alzheimer's dementia.

Source: Phytomedicine 2000 Jan;6(6):393-401

©2008 ProHealth, Inc.
(http://www.alzheimersupport.com)
All Rights Reserved.
Email article to a Friend | Printer Friendly Page

Related Articles

  • Ginkgo Biloba and Phosphatidyl Choline Improve Cognitive Function   READ ARTICLE
  • Ginkgo Improves Brain Function, Extends Life Span   READ ARTICLE
  • Ibuprofen Could Delay Onset of Alzheimers Disease  READ ARTICLE
  • Creatine May Offer Protection to Alzheimers Patients  READ ARTICLE
  • Alzheimer Disease is Added to the Growing List of Diet-Related Chronic Conditions  READ ARTICLE
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community | Affiliates


ProHealth's AlzheimerSupport.com-
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee